NCT00975065View on ClinicalTrials.gov

Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

266

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

April 30, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

vildagliptin 50 mg bid plus metformin 1500mg (Galvus+Diabex)

vildagliptin 50 mg bid plus metformin 1500mg

DRUG

metformin 1500mg plus metformin 500mg or 1000mg (Diabex)

metformin 1500mg plus metformin 500mg or 1000mg

Trial Locations (1)

Unknown

Handok Pharmaceuticals, Seoul

Sponsors

Lead Sponsor

Handok Inc.
All Listed Sponsors
lead

Handok Inc.

INDUSTRY

NCT00975065 - Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter